Whittaker, R G <br/><br/>
Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation.  [electronic resource] 

 -  Neurology  Feb 2009 
 - 568-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.wnl.0000342121.91336.4d  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>DNA, Mitochondrial--genetics<br/>Female<br/>Genetic Predisposition to Disease--genetics<br/>Genetic Testing--methods<br/>Humans<br/>Male<br/>Middle Aged<br/>Mitochondrial Diseases--diagnosis<br/>Mutation<br/>Outcome Assessment, Health Care--methods<br/>Prognosis<br/>RNA Precursors--genetics<br/>RNA, Transfer, Leu--genetics<br/>Reproducibility of Results<br/>Sensitivity and Specificity